Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Authors
Gore, MSzczylik, C
Porta, C
Bracarda, S
Bjarnason, G
Oudard, S
Lee, S
Haanen, J
Castellano, D
Vrdoljak, E
Schöffski, P
Mainwaring, P
Hawkins, Robert E
Crinò, L
Kim, T
Carteni, G
Eberhardt, W
Zhang, K
Fly, K
Matczak, E
Lechuga, M
Hariharan, S
Bukowski, R
Issue Date
2015-06-30
Metadata
Show full item recordAbstract
We report final results with extended follow-up from a global, expanded-access trial that pre-regulatory approval provided sunitinib to metastatic renal cell carcinoma (mRCC) patients, ineligible for registration-directed trials.Citation
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma. 2015, 113 (1):12-9 Br J CancerJournal
British Journal of CancerDOI
10.1038/bjc.2015.196PubMed ID
26086878Type
ArticleLanguage
enISSN
1532-1827ae974a485f413a2113503eed53cd6c53
10.1038/bjc.2015.196
Scopus Count
Collections
Related articles
- Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.
- Authors: Sternberg CN, Calabrò F, Bracarda S, Cartenì G, Lo Re G, Ruggeri EM, Basso U, Gasparini G, Ciuffreda L, Ferrari V, Bonetti A, Fea E, Gasparro D, Tassinari D, Labianca R, Masini C, Fly K, Zhang K, Hariharan S, Capaccetti B, Porta C
- Issue date: 2015
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
- Authors: Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S, Hariharan S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring P, Nieto A, Yuan J, Bukowski R
- Issue date: 2009 Aug
- [Comparison of efficacy between sorafenib and sunitinib as first-line therapy for metastatic renal cell carcinoma and analyze prognostic factors for survival].
- Authors: Cai W, Yuan YC, Li MY, Kong W, Dong BJ, Chen YH, Zhang J, Xue W, Huang YR, Zhou LX, Huang JW
- Issue date: 2018 May 23
- Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with renal insufficiency.
- Authors: Kim KH, Kim HY, Kim HR, Sun JM, Lim HY, Lee HJ, Lee S, Bae WK, Rha SY, Korean Cancer Study Group., Genitourinary & Gynecology Cancer Committee.
- Issue date: 2014 Mar
- Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients.
- Authors: Donskov F, Michaelson MD, Puzanov I, Davis MP, Bjarnason GA, Motzer RJ, Goldstein D, Lin X, Cohen DP, Wiltshire R, Rini BI
- Issue date: 2015 Dec 1